Prediction of postoperative delirium after cardiac surgery by the interplay between preoperative plasma p-tau181 and IL-6 and heart-brain axis related factors: results from the prospective observational study FINDERI
Postoperative delirium (POD) following cardiac surgery is a severe complication. There is evidence of a link between neuroinflammation and neurodegeneration in POD. We investigated the preoperative proinflammatory interleukin-6 (IL-6) and neuronal damage marker phosphorylated tau protein 181 (p-tau181) to POD while considering preoperative heart-brain axis related factors. The prospective FINd DElirium RIsk factors (FINDERI) is an observational study in patients undergoing cardiac surgery. Biomarkers IL-6 and p-tau181 were measured in blood samples. For statistics, we utilized multiple logistic regression analyses and advanced machine learning techniques. In 491 patients, 106 (21.6%) developed POD. The age of patients with POD was significantly higher than that of patients without POD (p < 0.001). Preoperative IL-6 and p-tau181 levels independently predicted POD [IL-6: area under the curve (AUC) = 0.605, p < 0.005; p-tau181: AUC = 0.641, p < 0.0001)]. A multiple logistic regression analysis of preoperative log-transformed biomarkers levels (p-tau181, IL-6), female sex and cognitive performance increased the AUC (0.710, p < 0.0001) in predicting POD. We created a decision tree prediction model including preoperative p-tau181, IL-6, and the severity of mitral valve disease (training data: AUC = 0.672, p < 0.0001; validation data: AUC = 0.642, p < 0.05). The LASSO regression showed an increased AUC in the training (0.751, p < 0.0001) and validation dataset (0.652, p < 0.05). Our results demonstrate that the combined assessment of preoperatively measured p-tau181 and IL-6, preoperative mitral valve disease, cognitive performance and female sex, significantly predicts POD. These findings provide evidence that neuroinflammation and neuronal cell damage are associated with POD.
Authors
- Mohammed Chebbok
- Katharina Packroß
- Charlotte Eberhard
- Santander Martínez
- Ingo Kutschka (ORCID: https://orcid.org/0000-0002-7358-3513)
- M. Richter
- Manuel Johannes
- Irina Günther
- Christopher M. Celano (ORCID: https://orcid.org/0000-0003-0547-2851)
- Julia Ehrentraut
- Monika Sadlonova (ORCID: https://orcid.org/0000-0003-3629-252X)
- Maria Knierim (ORCID: https://orcid.org/0000-0001-8380-5215)
- Ihtzaz Ahmed Malik (ORCID: https://orcid.org/0000-0002-6712-0838)
- J. E. Schmitz (ORCID: https://orcid.org/0000-0002-8817-8801)
- C. Knopp
- Adriana Wiesent
- Stephanie Heinemann (ORCID: https://orcid.org/0000-0002-3937-5956)
- Hermann Esselmann (ORCID: https://orcid.org/0000-0001-5484-9710)
- Alina Isabel Rediske
- Bárbara Morgado (ORCID: https://orcid.org/0000-0001-8174-9301)
- Iryna Krasiuk
- Tobias Titsch
- Björn H. Schott (ORCID: https://orcid.org/0000-0002-8237-4481)
- Hassina Baraki (ORCID: https://orcid.org/0000-0003-3938-6484)
- Carlotta Derad (ORCID: https://orcid.org/0000-0001-9542-4647)
- Paul T. Itting
- F E Bauer
- Anne-Catherine Thiel
- Sandra Kastenbauer
- Manuel J. Santander
- Theresa Maria Kruck
- Annika Gaß
- Maike Hohberg
- Britta Albert
- Anke Jahn-Brodmann
- Christine A. F. von Arnim
- Rebecca Arentz
- Miriam F. Schröder
- Tendai Chiwakata
- Niels Hansen
- FINDERI investigators
- Michael Moser
- Maria Alexy
- Thomas Asendorf
- Jens Wiltfang
- Matilda-Marie Becker
- Melania Hotheit
- Sophie Doerfler
- Nicholas Paul Süttmann
- Maria Dornieden
Institutions
- Harvard University (US)
- German Center for Neurodegenerative Diseases (DE)
- Massachusetts General Hospital (US)
- Universitätsmedizin Göttingen (DE)
- German Centre for Cardiovascular Research (DE)
- University of Aveiro (PT)
- University of Göttingen (DE)
Publication Details
- Journal
- Molecular Psychiatry
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1038/s41380-025-03412-3
- Primary Topic
- Intensive Care Unit Cognitive Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universidade de Aveiro
- Deutsche Herzstiftung
- National Heart, Lung, and Blood Institute